177 related articles for article (PubMed ID: 38052016)
1. A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis.
Ding G; Tang G; Wang T; Zou Q; Cui Y; Wu J
Int J Surg; 2024 Mar; 110(3):1735-1743. PubMed ID: 38052016
[TBL] [Abstract][Full Text] [Related]
2. Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
Kong J; Lichtbroun B; Sterling J; Wang Y; Wang Q; Singer EA; Jang TL; Ghodoussipour S; Kim IY
Am J Clin Exp Urol; 2022; 10(2):73-81. PubMed ID: 35528467
[TBL] [Abstract][Full Text] [Related]
3. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis.
Cacciamani GE; Maas M; Nassiri N; Ortega D; Gill K; Dell'Oglio P; Thalmann GN; Heidenreich A; Eastham JA; Evans CP; Karnes RJ; De Castro Abreu AL; Briganti A; Artibani W; Gill I; Montorsi F
Eur Urol Oncol; 2021 Apr; 4(2):134-149. PubMed ID: 33745687
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of comparative studies on the efficacy of extended pelvic lymph node dissection in patients with clinically localized prostatic carcinoma.
Gao L; Yang L; Lv X; Bu S; Wan F; Qian S; Wei Q; Han P; Fan T
J Cancer Res Clin Oncol; 2014 Feb; 140(2):243-56. PubMed ID: 24369378
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.
Liss MA; Palazzi K; Stroup SP; Jabaji R; Raheem OA; Kane CJ
World J Urol; 2013 Jun; 31(3):481-8. PubMed ID: 23512231
[TBL] [Abstract][Full Text] [Related]
6. Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis.
Qi W; Zhong M; Jiang N; Zhou Y; Lv G; Li R; Shi B; Chen S
Front Oncol; 2022; 12():986150. PubMed ID: 36505883
[TBL] [Abstract][Full Text] [Related]
7. Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates.
Nagaya N; Chua KJ; Sterling J; Horie S; Kim IY
Prostate Int; 2023 Jun; 11(2):107-112. PubMed ID: 37409090
[TBL] [Abstract][Full Text] [Related]
8. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
[TBL] [Abstract][Full Text] [Related]
9. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
10. Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis.
Choo MS; Kim M; Ku JH; Kwak C; Kim HH; Jeong CW
Ann Surg Oncol; 2017 Jul; 24(7):2047-2054. PubMed ID: 28271172
[TBL] [Abstract][Full Text] [Related]
11. Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis.
Zhang X; Zhang G; Wang J; Bi J
World J Surg Oncol; 2023 Mar; 21(1):80. PubMed ID: 36872312
[TBL] [Abstract][Full Text] [Related]
12. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies.
Bi L; Huang H; Fan X; Li K; Xu K; Jiang C; Liu H; Dong W; Zhang S; Yang X; Lin T; Huang J
BJU Int; 2014 May; 113(5b):E39-48. PubMed ID: 24053715
[TBL] [Abstract][Full Text] [Related]
13. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
[TBL] [Abstract][Full Text] [Related]
14. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
16. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
Eden CG; Arora A; Rouse P
BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
[TBL] [Abstract][Full Text] [Related]
17. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer.
Colicchia M; Sharma V; Abdollah F; Briganti A; Jeffrey Karnes R
Curr Urol Rep; 2017 Jul; 18(7):51. PubMed ID: 28589397
[TBL] [Abstract][Full Text] [Related]
19. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
[TBL] [Abstract][Full Text] [Related]
20. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
